Precision Oncology

Making the Impossible Possible at GC Genome.

Empower patients by providing accurate and timely information for the diagnosis and prognosis of specific cancers.


Germline mutations are genetic alterations that take place in a parent’s reproductive cells (egg or sperm), thereby affecting the genetic material inherited by their child. These mutations are hereditary and can be inherited from either parent.

GCG Women’s Cancer Panel

A comprehensive genetic test specifically designed to identify
germline mutations associated with women’s cancer.
Anyone with a personal or family history of Breast Cancer or Ovarian
Cancer is recommended to take this test.

Hereditary Cancer Panel

A specialized genetic test that focuses on detecting hereditary
mutations linked to different types of cancer.


Somatic mutations refer to DNA changes that occur in any cell of an individual’s body, except for the germ cells (egg or sperm cells), after conception. Unlike germline mutations, somatic mutations are not inherited from parents and are not passed on to future generations. They occur sporadically or randomly, without being present in a person’s family history.

Hematology Cancer Panel

Genetic diagnosis, treatment, and prognostic testing for hematological cancer patients;

– Acute Myeloid Leukemia (AML)
– Acute Lymphoblastic Leukemia (ALL)
– Myelodysplastic Syndrome (MDS)/Myeloproliferative Neoplasms(MPN)
– Lymphoma
– Multiple Myeloma

Solid Tumor Panel

Genetic diagnosis, treatment, and prognostic testing for solid tumor patients.
All-in-one test to discover all you need to know for target therapy and immunotherapy selection for cancer patients.

Liquid Biopsy

A non-invasive genetic test that analyzes genetic material (such as circulating tumor DNA) obtained from a blood sample, aiding in detecting and monitoring cancer.

HRD(Homologous recombination deficiency)

A test used to identify patients who are potential candidates for the prescription of PARP (Poly ADP-Ribose Polymerase) inhibitors, the major targeted anticancer agents for ovarian cancer patients.